CYTOKINETICS INC
CYTK · NASDAQ
Updated at 2026-10-14 12:34:30
- Today's High
- $63.05
- Today’s Low
- $61.50
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $62.48
- Previous Close
- $62.79
- Volume
- 1.25M
- Market Cap
- $8.72B
- P/E Ratio
- --
- EPS
- $-7.22
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080
- Country
- US
- Listing Date
- 2004-04-29
- Fiscal Year End
- December
- Shares Outstanding
- 135.58M
- CIK
- 0001061983
- Website
- cytokinetics.com
Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.
Financial Metrics
Revenue
2026-06-30
$31.91M
2026-03-31
$19.35M
2025-12-31
$17.75M
2025-09-30
$1.93M
Operating Expenses
2026-06-30
$205.06M
2026-03-31
$200.58M
2025-12-31
$193.26M
2025-09-30
$166.01M
Net Income
2026-06-30
-$198.76M
2026-03-31
-$206.03M
2025-12-31
-$183.03M
2025-09-30
-$306.17M
Net Profit Margin
2026-06-30
-622.8%
2026-03-31
-1.06K%
2025-12-31
-1.03K%
2025-09-30
-15.81K%
Earnings Per Share
2026-06-30
$-1.50
2026-03-31
$-1.67
2025-12-31
$-1.50
2025-09-30
$-1.54
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$195.13M
2026-03-31
-$169.31M
2025-12-31
-$180.17M
2025-09-30
-$277.17M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $31.91M | $19.35M | $17.75M | $1.93M |
| Operating Expenses | $205.06M | $200.58M | $193.26M | $166.01M |
| Net Income | -$198.76M | -$206.03M | -$183.03M | -$306.17M |
| Net Profit Margin | -622.8% | -1.06K% | -1.03K% | -15.81K% |
| Earnings Per Share | $-1.50 | $-1.67 | $-1.50 | $-1.54 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$195.13M | -$169.31M | -$180.17M | -$277.17M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.